Nav: Home

A lot of blood, for no reason? Review shows that common, costly clot test has few benefits

November 02, 2016

ANN ARBOR, Mich. -- A half billion dollars - at least -- gets spent each year on blood tests to see which hospital patients have a genetic quirk that makes their blood more likely to form dangerous clots.

And most of that spending probably isn't necessary, according to a new paper by a University of Michigan Medical School team.

Writing in the Journal of Hospital Medicine, they review what's known about testing for the trait called inherited thrombophilia, and call for a drastic cut in the test's use by doctors across America.

After all, they write, hospitalized people who have already had such dangerous clots, called venous thromboembolisms or VTEs, don't need a positive genetic test to justify taking medication and making other changes to prevent future ones.

And there's no evidence that medication to prevent clots will help hospital patients who haven't yet had a VTE. Testing their DNA for inherited thrombophilia won't change that.

In other words, the authors say, ordering inherited thromboembolism testing on inpatients is something doctors do for little or no reason. And according to the team's analysis of data pulled from medical records, they do it hundreds of thousands of times a year in Medicare patients alone.

Often, it appears, the test gets ordered to satisfy curiosity about why a patient had a VTE, to see if they're among the seven percent of Americans with a genetic mutation that makes blood more prone to clot.

There are several tests for several traits, so patients often get them in combination - what's called a "hypercoagulable workup." But if doctors are following guidelines grounded in evidence, the test result should rarely change a patient's care.

So, except in very specific cases where such clots are highly likely - such as women with a family history of clots who are pregnant or getting hormone replacement therapy - there's probably not much reason to do the test at all.

Resisting temptation

"More testing is not always better," says Christopher Petrilli, M.D., an assistant professor of internal medicine at U-M and co-first author of the new paper.

"Testing for this disorder is almost never beneficial, and in fact can even be harmful because it can cause undue psychological distress for the patient, and unnecessary expense for the healthcare system," he adds.

"Physicians and patients should resist the temptation to perform costly search for an underlying genetic cause of venous thrombosis," says co-first author Lauren Heidemann, M.D., also an assistant professor of medicine.

Petrilli and Heidemann - both hospitalists who specialize in treating patients in the U-M Health System's University Hospital -- have set out to address such "no reason" testing at UMHS and beyond.

They've co-founded a local chapter of the group Providers for Responsible Ordering, which aims to help physicians, nurse practitioners and physician assistants reduce over-testing and use health care resources appropriately.

They've also led the effort to make UMHS one of more than 40 founding members of the High Value Practice Academic Research Alliance, which is working to bring institutions together to help one another implement strategies that make better use of resources.

The current climate of public attention on new genetic testing options and personalized medicine could make this difficult in some cases, they note in the paper.

Ideally, genetic tests to find out whether someone carries a certain genetic trait should be used when there's clear information about the risks, benefits and costs of that test.

"With national health care spending reaching an unsustainable level, we as physicians need to be vigilant about becoming stewards of health care resources," says Heidemann.

Reviewing the evidence

For the paper, Petrilli, Heidemann and their colleagues reviewed the full scope of literature and established guidelines on inherited thrombophilia testing. They illustrated the situation by applying this information to a hypothetical case of a young patient with a VTE but no family history who suffers a pulmonary embolism - a dangerous health emergency where clots form in the lower extremities and travel to the lungs, potentially cutting off oxygen to the body unless treatment starts quickly.

They note the conclusions about VTE prevention and treatment that have been reached by several medical bodies - including an American College of Chest Physicians guideline recommending against giving clot-prevention medication to people with the genetic trait but no VTE history.
-end-
A group that looks at genetic testing, the Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group, concluded that tests for inherited thrombophilia were likely not cost-effective.

In addition to Petrilli and Heidemann, the research team included senior author Vineet Chopra, M.D., M.Sc., a hospitalist and assistant professor of general medicine, as well as assistant professor Megan Mack, M.D. and UMHS financial analyst Paul Durance, Ph.D. Petrilli, Heidemann and Chopra are members of the U-M Institute for Healthcare Policy and Innovation.

The new paper is part of the Journal of Hospital Medicine's series called Choosing Wisely: Things We Do for No Reason. It's published in the November 2016 issue. Reference: J. Hosp. Med., 11: 801-804. doi:10.1002/jhm.2616

University of Michigan Health System

Related Medication Articles:

ADHD medication: How much is too much for a hyperactive child?
When children with ADHD don't respond well to Methylphenidate (MPH, also known as Ritalin) doctors often increase the dose.
Pain medication use by children after common surgeries
About 400 caregivers reported pain medication use by children after common surgeries such as hernia, elbow fracture, appendectomy or adenoid removal in this study.
Bringing cancer medication safely to its destination
Treating cancer more selectively and more effectively -- this could be achieved with an innovative technology developed by teams of researchers at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) and the Ludwig-Maximilians-Universität München (LMU).
Bullying linked to student's pain medication use
In a school-based survey study of all students in grades 6, 8, and 10 in Iceland, the use of pain medications was significantly higher among bullied students even when controlling for the amount of pain they felt, as well as age, gender, and socioeconomic status.
New medication gives mice bigger muscles
Researchers from Aarhus University, Denmark, have studied a new group of medicinal products which increase the muscle- and bone mass of mice over a few weeks.
Diabetes medication may protect against a common cause of blindness
Researchers from Taiwan have shown that people with type 2 diabetes who took a common diabetes medication, metformin, had a significantly lower rate of age-related macular degeneration (AMD).
Apps a timely reminder for those on heart medication
New research from the University of Sydney shows mobile apps could potentially save lives by helping people with coronary heart disease keep on top of their medication.
What are the trends in prescription medication use among US children and teens?
Estimates of prescription medication use by US children and adolescents declined overall from 1999 to 2014 and patterns of use varied by medication class.
Do the elderly want technology to help them take their medication?
Over 65s say they would find technology to help them take their medications helpful, but need the technology to be familiar, accessible and easy to use, according to research by Queen Mary University of London and University of Cambridge.
Dementia diagnosis linked to unnecessary medication use
A new international study led by University of Sydney has found that medication use increases in newly diagnosed dementia patients, particularly unnecessary or inappropriate medications.
More Medication News and Medication Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.